






GENETICALLY ENGINEERED (GE) VARIETIES OF TOMATOES WERE MARKETED IN THE UNITED STATES 
FOR SEVERAL YEARS NOTABLY CALGENEʹS ʺFLAVRSAVRʺ TOMATO. CURRENTLY, THERE ARE NO GE 
TOMATOES ON THE MARKET. 
 
Frequently Asked Questions 
 
Am I eating genetically engineered tomatoes? 
The short answer is no.  Several genetically engineered tomato  
varieties have been developed in the United States and 
approved for commercialization, some of which were available 
in limited markets for a few years in the mid-1990s. For a 
variety of reasons these GE tomatoes are no longer marketed, 
and currently no GE tomatoes are present in U.S. markets 
either as whole tomatoes or in processed tomato foods. 
 
What genetically engineered traits were added 
to tomatoes? 
At present, tomatoes are the only food that has been marketed 
with GE delayed-ripening traits.  Delaying the ripening 
process in tomatoes is of interest to producers because it allows 
more time for shipment of tomatoes from the farmerʹs fields to 
the grocerʹs shelf, and increases the shelf life of the tomatoes 
for consumers.  Although ripening makes tomatoes edible and 
flavorful, it also begins the gradual decline towards softening 
and rot, causing losses for producers and consumers.  Tom-
atoes that are genetically engineered to have delayed ripening 
can be left longer on the plant to mature, will have longer 
shelf-life in shipping, and may last longer for consumers. 
   Some tomatoes have been genetically engineered to alter one 
particular aspect of tomato ripening: softening. The process of 
fruit softening is caused in part by the breakdown of pectins-- 
compounds which give support to the walls of tomato cells. 
Tomatoes have been engineered to have reduced levels of a 
pectin breakdown enzyme called polygalacturonase.  This not 
only increases shelf life, it makes the tomato products thicker 
(higher pectin to water ratio), which is of interest to tomato 
processors.  This is the technique used in the well-known 
ʺFlavrSavrʺ tomato (see below). 
   Tomato plants naturally produce the compound ethylene to 
trigger the ripening of tomatoes on the plant.   Several genetic 
engineering strategies involve the reduction or prevention of 
ethylene production to slow or stop the ripening process.  To 
date, however, no genetically engineered tomatoes using this 
strategy have been marketed. 
 
What is the history and prevalence of GE 
tomatoes? 
The first genetically engineered food to test the U.S regulatory 
system was Calgeneʹs ill-fated FlavrSavr tomato, which 
utilized the pectin-based strategy of delayed softening 
(described above).   In late 1991, Calgene had a variety of 
FlavrSavr tomato ready for marketing and requested the 
opinion of the U.S. Food and Drug Administration (FDA).  In 
May 1992, the FDA approved the safety of the new variety, 
and Calgene announced that the FlavrSavr would be available 
in test markets after the 1993 growing season. 
   In early 1993, public concerns about food safety prompted 
Calgene to request a ruling from the FDA regarding the safety 
of antibiotic resistance genes in GE foods.   Although Calgene 
had tomatoes ready for shipment, by the end of the year the 
FDA still had not issued a new ruling, and the 1993 harvest 
was never marketed. 
   Calgene was not alone in the race for the first GE tomato. 
Campbell Soup Co., which had collaborated with Calgene to 
develop the technology, had also been supporting the UKʹs 
Zeneca Seeds to develop another delayed-ripening tomato 
using the same technology.  Threatening mutual lawsuits, 
Campbell, Calgene, and Zeneca worked out a compromise in 
February of 1994: Calgene would be given the world-wide 
rights to sell the fresh-market types of the new tomato, while 
Zeneca would focus exclusively on processing tomato 
applications.  Although the tomatoes had to be grown in 
California, in the UK Zeneca contracted the Safeway and 
Sainsbury grocery chains to sell the worldʹs first (and only) GE 
tomato paste. The product was clearly labeled as ʺmade with 
genetically modified organisms,ʺ was considerably less 
expensive than tins of conventional brands (delayed-ripening 
made processing cheaper), and was very popular for several 
years (an estimated 60 percent share of canned tomato market 
in 1999).  These products were pulled from shelves in the UK 
several year later, following the increasing unpopularity of GE 
foods in the UK. 
   Introduction of the FlavrSavr into U.S. markets was more 
problematic for Calgene.  Like Zeneca, Calgene received FDA 
approval for its tomatoes in mid-1994. That summer the 
FlavrSavr tomatoes, under Calgeneʹs ʺMacGregorsʺ brand, 
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arrived in markets in the Chicago area. The tomatoes were 
clearly labeled as ʺgenetically modifiedʺ and were 
accompanied by information pamphlets. Despite growing 
protests by activist groups (notably Jeremy Rifkin), the 
tomatoes were well received and Calgene had difficulty 
keeping up with demand. 
   But by early 1995, Calgene was showing signs of trouble: 
Calgene had contracted farmers directly to grow the FlavrSavr, 
and attempted to control the distribution and marketing 
system itself.  Technical problems made it difficult to ship the 
delicate GE tomatoes without damage, the tomatoes hadnʹt 
grown well in Florida production fields, and Calgene was hit 
hard by high development costs and several years of low 
tomato prices.  A patent-infringement lawsuit brought against 
Calgene by Monsanto may have been a final blow: Calgene 
agreed to sell a 49.9 percent share to Monsanto in July 1995, 
and by October that fraction was upped to 54.6 percent. 
Calgene sustained its dwindling supply of the FlavrSavr 
throughout 1996 (including some markets in Canada). By the 
beginning of 1997, however, it became apparent that 
production problems might be insurmountable, and Monsanto 
announced that it would buy the remaining shares of the cash-
strapped Calgene. By March 1997, there were no more 
FlavrSavr tomatoes left to be found, less than three years after 
their introduction. 
   Also, in the mid-1990s, three additional companies attempted 
to develop GE delayed-ripening tomatoes, using the ethylene-
reduction approach (described above).  DNA Plant Technolo-
gies (DNAP), Monsanto, and Agritope gained regulatory 
approval to market such varieties, but to date none of these 
have been marketed.  Yet research continues: Monsanto, 
Calgene, Agritope, Aventis, DNA Plant Technologies, Seminis, 
and others are currently attempting to develop new varieties of 
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If you’d like to learn more about genetic engineering, visit 
the GEO-PIE Project web site at 
 
www.geo-pie.cornell.edu 
 
 
 
 
 
 
 
